Leadership & Pay ·
Accendra Health announced it will not implement an at-the-market equity issuance program intended to reduce…
ACHAccendra Health Inc
Accendra Health announced it will not implement an at-the-market equity issuance program intended to reduce indebtedness, citing current market conditions and sufficient liquidity from its undrawn $300 million revolving credit facility. The company confirmed the closure of one non-core asset sale in Q3 and expects a second to close by year-end, generating approximately $45 million in cash with de minimis impact on Adjusted EBITDA. Additionally, the Board plans to announce a new CEO successor by mid-September 2026, ahead of outgoing CEO Mr. Pesicka's planned retirement at the end of the year. Accendra Health is a provider of home-based care products and services for chronic conditions.